FDA Warning Letter — BP

Case 538669 — FEI 3013873979

The FDA took a Warning Letter action against BP on Oct 5, 2017 (Cleveland, OH). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
BP
Date
Oct 5, 2017
Fiscal Year
2018
Product Type
Tobacco
Center
CTP
Location
Cleveland, OH (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.